© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
127626 |
As an accredited 2-Bromo-5-Fluoropyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Bromo-5-Fluoropyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Walking into a lab, there’s a comfort in having reagents you can trust, especially when dealing with complex syntheses. 2-Bromo-5-Fluoropyridine has earned its place among key intermediates in pharmaceuticals and agrochemicals thanks to its stability and versatility. Out of the molecule toolbox, few offer the precise halogen arrangement of this pyridine derivative—bromine at the 2-position and fluorine at the 5-position—without complicating reactivity. That very arrangement opens doors in cross-coupling reactions, knocking down barriers that chemists run into with less cooperative compounds.
Its model designation, 2-Bromo-5-Fluoropyridine, points straight to its structure: a six-ring nitrogen framework with bromine and fluorine substituents. The impact of this setup makes itself known as soon as Suzuki and Stille couplings come into focus. In pharmaceutical research, this compound helps in crafting scaffolds for novel kinase inhibitors and other drug leads where fluorine substitution tailors the molecule’s metabolism and binding properties.
Practically, this chemical appears as a crystalline solid with a relatively high level of purity. Handling feels manageable, as its melting point sits comfortable for standard storage without fuss. The compound dissolves cleanly in a variety of organic solvents, sidestepping issues that plague less forgiving halopyridines. You won’t run into a sticky mess or unpredictable degradation; each batch tends to behave predictably, matching analytical specs and letting chemists focus on the molecular puzzle in front of them.
In the flow of medicinal chemistry, the choice of reagent shapes both the efficiency and integrity of what rolls off the bench. I've seen first-hand how having dependable 2-Bromo-5-Fluoropyridine on hand tilts experiments toward success—especially when timelines and budgets run tight. As labs push for patentable molecules, there's no room for wildcard inputs that bring inconsistency. Synthetic routes based on this compound often result in fewer impurities, as the direct halogenation pattern bypasses the need for protecting group gymnastics or redundant purification steps.
On industrial scales, it enables scale-up of targeted molecules without introducing byproduct headaches. That means fewer purification columns and lower waste, which isn’t just good for process economics—it’s critical in an age where regulatory scrutiny around manufacturing waste only grows sharper. By sticking with reagents that play well with modern synthetic methodologies, researchers and industrial chemists can hit their yield marks without sacrificing the quality benchmarks regulators and downstream users have come to expect.
Looking across similar halopyridine products, the subtlety lies in the balance of reactivity. Monohalogenated pyridines often fall short when trying to blend selective reactivity with manageable handling. Adding a second halogen, as in 2-Bromo-5-Fluoropyridine, broadens reaction scope: bromine offers a handle for cross-coupling, while fluorine tunes the electronic and metabolic properties of final molecules. In contrast, analogs like 2-Chloro-5-Fluoropyridine or 2-Bromo-3-Fluoropyridine might seem similar, but their distinctive electronic footprints and coupling performances show up quickly in practice. Tweaking from bromine to chlorine changes the reactivity window, making reactions fussier, sometimes slower, or prone to side reactions.
In my work, switching between halogenated pyridines came with its own set of surprises. I’ve watched yields plummet because a less reactive chlorine at the 2-position slowed a Suzuki coupling to a crawl. With fluorine at the 5-position, though, you get a boost for certain target interactions—especially when building molecules for specific receptor or enzyme selectivity. The 2-bromo variant doesn’t just survive purification; it does so while anchoring the pathway for more complex functionalization, leading to a greater array of accessible molecular diversity in a single synthetic campaign.
Pharmaceutical companies dip into their supply of 2-Bromo-5-Fluoropyridine during lead optimization, hunting for ways to insert fluorine into ring systems and tweak pharmacokinetics. Medicinal chemists reach for it again as a cross-coupling substrate, building everything from small molecule inhibitors to radio-labeled probes. Beyond pharma, crop science researchers build on its backbone to generate new candidates that improve pest resistance without spiking toxicity. The compound’s well-defined reactivity plays a key role in ensuring that scale-up batches retain the same fingerprint and high purity as the very vials used on the bench.
Talking to colleagues in analytical departments, I’ve learned that this compound’s clean profile in GC-MS and NMR translates into less troubleshooting—and lower risk of misidentifying structural isomers or contaminants. Because its halogen pattern doesn’t shift easily under standard conditions, it grants chemists certainty as they trace reaction mechanisms or debug synthetic hiccups. In roundtable discussions, common frustrations with analogs often circle back to inconsistent GC peaks or confounding byproducts obscuring downstream analysis.
From firsthand experience, 2-Bromo-5-Fluoropyridine doesn’t demand elaborate storage rituals. It tolerates typical ambient temperatures and lacks the volatility of lighter pyridine derivatives, making it friendlier for day-to-day handling. This helps labs avoid scrambling for refrigeration space or worrying over rapid degradation that creeps up with other halogenated compounds. Purity holds steady over moderate timescales, ensuring that open containers don’t immediately compromise sensitive experiments.
I’ve worked in labs where pounds of basic halopyridines went bad after a few months because minor decomposition wasn’t caught in time. That cautionary tale doesn’t tend to play out with this product, as its shelf stability matches its reactivity, holding strong until every last gram is put to use. In practice, that stability means you start reactions knowing the limiting reagent—the 2-Bromo-5-Fluoropyridine—won’t quietly sabotage your results through unmonitored breakdown.
Pushing for reliable synthesis hinges on purity, particularly for pharma and crop science. Laboratories and manufacturers typically set the bar at 98% or higher, gauging every lot with HPLC, NMR, and MS. Consistent high-purity 2-Bromo-5-Fluoropyridine means confidence in downstream transformations, with fewer shadows in the spectra pointing to potential byproducts or unreacted starting material. This clarity shortens project timelines, freeing up resources and reducing the frequency of last-minute troubleshooting.
Years spent cleaning up after impure batches drive home the hidden costs that come from shortcuts. A high-quality batch cuts out the noise in structure-activity studies, avoiding wild goose chases that emerge from uncontrolled impurities skewing biological data. Testing a drug candidate with inconsistently pure intermediates can derail whole projects, wasting not just money but months of labor that organizations can’t afford to lose.
Crossing into pilot and full-scale runs, 2-Bromo-5-Fluoropyridine’s performance matters all the more. Customers in pharmaceutical manufacturing often need to transfer bench-scale recipes to industrial reactors, and choosing the right halopyridine determines whether scale-up will hit throughput targets or bog down with unexpected byproduct formation. In these larger reactors, side reactions that barely register at 100 mg suddenly spiral into real impediments on kilo or ton scale. I’ve watched process chemists breathe easier knowing they can stake their project’s timeline and regulatory filings on a trusted intermediate like 2-Bromo-5-Fluoropyridine.
Quality control workers highlight another benefit: traceability and certification. Reliable sources provide full supply chain documentation, supported by thorough analytical data. Regulatory authorities increasingly stress this level of detail, which builds trust and speeds up audits. Pharmaceutical buyers now want to see not just a certificate of analysis, but a solid track record of performance batch after batch. Here, sticking with proven intermediates simplifies regulatory interaction and minimizes risk in later filings, which often translates directly into a smoother pathway for product launches.
No chemical solution is perfect. One real challenge with halopyridine procurement is market stability—fluctuating prices and inconsistent supply can throw project planning into chaos. Companies have faced interruptions, sometimes due to upstream shortages or new international regulations affecting halogenated feedstocks. I’ve seen projects stall for weeks, with research teams forced to pivot or redesign routes just because a regular supplier hit pause on shipments.
Addressing supply chain risk calls for building supplier redundancy from the start. Relying on a single vendor may be tempting for volume discounts, but in practice, setting up qualification for two or three reputable sources provides insurance against sudden market changes. Onboarding new suppliers takes upfront effort in quality checks and documentation review, but after seeing firsthand what happens during a raw material crunch, it’s clear this investment repays itself.
Productive intermediates like 2-Bromo-5-Fluoropyridine depend just as much on transparent specifications and trustworthy logistics as they do on molecular performance. Establishing stringent quality agreements with suppliers enforces standards, reducing the risk of out-of-spec deliveries. Colleagues in procurement and QA have found value in regular site audits and sample testing—even when this adds short-term cost, it preserves long-term continuity.
Patents have become a driving engine in synthetic innovation, and the use of pyridine derivatives sits at the intersection of chemistry and legal strategy. The substitution of fluorine and bromine isn’t just a matter of reactivity, but also provides freedom to operate in crowded intellectual property space. Molecules featuring the 2-Bromo-5-Fluoropyridine core allow researchers to chart new IP territory, especially when unique substitution patterns unlock unforeseen pharmacological activity or environmental benefits.
I’ve seen R&D teams pivot around expiration dates on basic 5-fluoropyridine patents, seeking clever ways to integrate 2-bromo substitution to claim new utility. This strategic advantage shortens the timeline from discovery to market while sidestepping infringement risk, pushing innovation forward and incentivizing companies to keep refining their core libraries.
Safe handling stands central to responsible lab leadership. With 2-Bromo-5-Fluoropyridine, typical best practices—gloves, goggles, well-ventilated hoods—suffice for routine use, since the chemical volatility remains low. Labs with institutional safety programs monitor halogenated waste and provide guidance on neutralization and disposal that complies with local, state, and national laws.
Proper labeling avoids costly mistakes; misidentified halopyridines can blend into waste streams, risking regulatory notice or safety incidents. I’ve worked alongside EH&S colleagues to build out waste tracking systems, including RFID scans or robust audit trails for chemical bins. These practices have paid off whenever inspections rolled in, giving labs and companies a stronger record of compliance and environmental stewardship.
Looking at future regulations, one pressing concern involves tightening controls on halogenated intermediates due to environmental persistence. Staying ahead of regulatory shifts means documenting not just the use, but also solvent choices, waste minimization, and end-of-life product fate. Early adoption of greener alternatives, solvent recycling, and improved waste capture practices fosters long-term resilience regardless of how requirements evolve.
Through a couple decades in synthetic labs, I’ve watched new chemical building blocks come and go. Some promise the world on paper, only to introduce headaches in storage, handling, or purification—especially at scale. 2-Bromo-5-Fluoropyridine has shown staying power because it bridges routine benchtop chemistry and demanding industrial applications without trade-offs that sandbag productivity.
I’ve reached for this molecule during crunch-time projects, and never regretted the choice. It brought reactions through to the finish line, saving weeks each time an easier pathway knocked out redundant steps or avoided hard-to-remove byproducts. Even among innovation-driven teams, its proven performance often tips the balance toward starting from a halogenated pyridine core rather than building up from scratch.
Looking ahead, the next frontier for this compound lies in how efficiently labs can integrate it into greener, more selective synthetic routes. Switching to continuous flow reactors, for instance, pairs well with its stability, streamlining hazardous steps and squeezing even more from every gram. Collaborations with manufacturers could encourage bulk synthesis methods that further decrease waste and energy use.
From academia to large-scale production, the shared objective is clear: balance versatility, reliability, and environmental impact. Sharing best practices for purification, scaling, and waste handling lifts the industry as a whole while protecting each organization’s unique edge.
2-Bromo-5-Fluoropyridine isn’t a panacea. Still, it’s a workhorse that keeps research and production on track, anchoring innovations in drug and agrochemical synthesis. Its unique combination of reactivity, stability, and ease of use helps technical staff and research leaders sleep better at night, knowing each batch will perform as expected, each time, across countless journeys from idea to finished product.
The enduring lesson: reliable intermediates like this one not only drive productivity—they safeguard the quality and creativity that set leading research apart. Choosing well, documenting thoroughly, and investing in supplier relationships forms the backbone of responsible, progressive chemistry. Having this compound in the pipeline puts teams in a position of strength, ready for whatever project timelines and regulatory shifts come next.
